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The activity of deoxyguanosine kinase purified from human placenta was regulated by various nucleotides. 
dTTP, an activator, only increased the V max value of the enzyme. The feedback inhibition by dGTP, dGDP 
and dGMP were competitive with respect to deoxyguanosine. Both the activation by dTTP and the 
inhibition by dGTP were reversible. 
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1. INTRODUCTION 
As immunodeficiency is associated with dGTP 
accumulation [l-3], due to a lack of purine 
nucleoside phosphorylase activity, the phospho- 
rylation of deoxyguanosine is considered impor- 
tant. In mammalian cells, cytosomal deoxycytidine 
kinase (EC 2.7.1.74) and mitochondrial deoxy- 
guanosine kinase were capable of phosphorylating 
deoxyguanosine [4-lo]. Deoxyguanosine kinase 
was partially purified from various mammalian 
tissues [7-lo]. These studies showed that the 
phosphorylation of deoxyguanosine by deoxy- 
guanosine kinase differed in Km value for deoxy- 
guanosine, optimal pH and effects of nucleotides 
from that by deoxycytidine kinase. Deoxy- 
guanosine kinase activity is stimulated by dTTP 
[7,10] and inhibited by dGTP, dGDP and dGMP 
[7-lo]. Here, we report regulation of human 
placental deoxyguanosine kinase by: nucleotides; 
activator, dTTP; and inhibitors, dGTP, dGDP 
and dGMP. 
phosphoenolpyruvate and pyruvate kinase were 
from Sigma (St Louis MO) and Boehringer (Mann- 
heim). Other reagents were commercial prepara- 
tion of the highest purity available. 
2.2. Enzyme assay and protein determination 
Deoxyguanosine kinase activity was assayed at 
pH 7.4 (50 mM Tris-HCl) with 10,uM [8-“HI- 
deoxyguanosine, 10 mM ATP and 10 mM MgClz, 
as in [lo]. One unit of enzyme activity is defined as 
the amount catalyzing the phoshorylation of 
1 nmol deoxyguanosine for 1 min. Specific activity 
was defined as units. min-’ . mg protein-‘. Protein 
concentration was determined by the Lowry 
method [l l] using bovine serum albumin as a 
standard. 
2.3. Purification of enzyme 
2. MATERIALS AND METHODS 
2.1. Materials 
[8-3H]Deoxyguanosine (1.7 Ci/mmol) was from 
Amersham (Bucks). Nucleosides, nucleotides, 
Human placenta (300 g) stored at - 70°C was 
homogenized in 900 ml 50 mM Tris-HCl buffer 
(pH 8.0) contained 1 mM dithiothreitol. The 
homogenate was centrifuged at 20000 x g for 
20 min. Deoxyguanosine kinase was purified from 
the supernatant by ammonium sulfate fractiona- 
tion (0-SSVo), affinity chromatography on 
AMR-Sepharose 4B, ion-exchange chromatogra- 
phy on DEAE-cellulose (Whatman, DE-52), gel 
filtration on Sephadex G-75, affinity chro- 
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matography on blue-Sepharose Cl-6B, then 
DE-52 column chromatography again, as in [IO]. 
To stabilize the enzyme activity, bovine serum 
albumin (0.2 mglml) was added to the final en- 
zyme prep~ation, and the preparation was stored 
at -7OT. 
3. RESULTS AND DISCUSSION 
The specific activity of the final enzyme prepara- 
tion was 10.3 nmol.min-’ . mg protein-” at pH 
6.0. When 10 mM ATP was used as a phosphate 
donor, the pH optimum was 6.0, but shifted to pH 
6.8 on the ad~tion of 1 mM dTTP [lo]. At 
physiological pH, the activity was stimulated 
2-fold by 0.2 mM dTTP and 3-4-fold by the op- 
timal concentration (fig.lA), Also by addition of 
CTP, dUTP and UTP (1 mM), the activity was 
stimulated 2.3-, 2.2- and 1.7-fold, respectively 
[lo]. By the activation of dTTP only the V,,, value 
of the enzyme was increased; the Km value for 
deoxyg~~osi~e was not affected (fig.tB). In the 
absence of dTTP, enzyme has 2 app. Z&-values for 
MgATP2-, 0.13 and 2.2 mM [lo]. However, on 
addition of dTTP, the low-affinity Km value for 
MgATP’- of 2.2 mM disappeared (fig.lC). 
In contrast, deoxyguanosine kinase activity was 
inhibited by the addition of a low concentration of 
dGTP and dGDP; app. &values of dGTP and 
dGDP were 1.0 and 2. PM, respectively (fig.2A). 
The activity was also inhibited by higher concen- 
trations of dGMP, GTP and dATP [lo]. An app. 
&value of dGMP was 0.33 mM. dGTP appeared 
to be a competitive inhibitor with respect to de- 
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Fig-l. (A) Effects of [dTTP] on deoxygu~osine kinase 
activity. (B) Double reciprocal plots for various 
deoxyguanosine concentrations: (M) none; (O--O) 
plus 1.0 mM dTTP. (C) Double reciprocal plots for 
various MgATP’- concentrations: (o----o) none; 
(o----o) plus 1.0 mM dTTP. 0.5 mM dTTP; (H) 1 .O mM dTTP. 
Fig.3. Combination effects of activator and inhibitor. 
Enzyme activity was assayed in the presence of various 
concentrations of inhibitor and activator. (A) Activation 
by dTTP: ( -) no dGTP; (o--O) plus 0.2pM 
dGTP; (a) 0.5 PM dGTP; (L%--&) 1.0&M dGTP; 
(CI) 2.0,~M dGTP; (o-a) 5.0,uM dGTP. (B) 
Inhibition by dGTP: (- ) no dTTP; (0-0) plus 
0.1 mM dTTP; (S) 0.2mM dTTP; (A-4) 
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Fi8.2. (A) Effects of dGTP or dGDP concentration on 
deoxyguanosine kinase activity: (O---Q) dGTP; 
(A--+) dGDP. (B) Double reciprocal plots for various 
deoxyguanosine concentrations: (+---o) none; (C---Q) 
plus 0.2pM dGTP. (C) Double reciprocal plots for 
various MgATP’- concentrations: (o---# none; 
(o--d) plus 0.2 pM dGTP. 
oxyguanosine (fig.2B). Furthermore, at >0.5 mM 
MgATP’-, the inhibition by dGTP became com- 
petitive with respect to MgATP’- (fig.2C). The 
same type of inhibition was observed by the addi- 
tion of appropriate concentrations of dGDP or 
dGMP . 
Combination studies were also carried out in the 
presence of activator and inhibitor (fig.3). The ad- 
dition of dTTP could reverse the inhibition due to 
dGTP. The activities stimulated by dTTP were 
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also decreased by further addition of dGTP. Thus, 
both the activation and inhibition were reversible. 
However, as the activity was strongly inhibited by 
low [dGTPj, to reverse the inhibition by 1 pM 
dGTP, 125 @I dTTP was necessary. 
Deoxyguanosine kinase seems to be dimer con- 
sisting of 2 identical subunits of MI 29000 [IO]. 
The regulation of the enzyme activity might be 
caused by the structural change of the enzyme. 
Therefore, we carried out sucrose density gradient 
analysis in the presence of activator (1 mM dTTP) 
or inhibitor (20 pM dGTP). However, the enzyme 
activity sedimented at the same position in the 
absence and presence of effecters. Thus, activation 
and inhibition were not caused by the association 
and dissociation of enzyme subunits. 
Deoxyguanosine kinase purified from human 
placenta was regulated by various nucleotides. It is 
of interest that the activity is stimulated by dTTP, 
CTP, dUTP and UTP. However, the activation 
was observed at higher physiological concentra- 
tions of these nucleotides [lo]. In contrast, the ac- 
tivity was strongly inhibited by a low concentration 
of dGTP or dGDP at both optimal pH and 
physiological pH. At physiological concentration 
of dGTP, the inhibition was readily observed. If 
deoxyguanosine were phosphorylated mostly by 
deoxyguanosine kinase, and not by deoxycytidine 
kinase, dGTP would not accumulate in T- 
lymphoblast in purine nucleoside phosphorylase 
deficiency. 
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